Dark

HTGM
HTG Molecular Diagnostics Inc
stock NASDAQ

At Close

1/27/2023 3:59:30 PM EST

4.17USD0.000%(0.00)153,572

3.35Bid 4.26Ask 0.91Spread IEX

Pre-market

1/27/2023 9:19:39 AM EST

4.23USD+1.439%(+0.06)300

After-hours

1/18/2023 4:00:30 PM EST

4.29USD0.000%(0.00)0

Overview HistoricalMore

open chart

Market Cap

4.265M

Headquarters

Tucson, Arizona, USA

Industry

Diagnostics & Research

Next Earnings

2023-03-30 (60d)

Last Split

2022-12-211for12reverse

EXEL RDUS AFMD CALA XLV

HTGM Stats

Avg. Vol. 10 Day

513,144

Avg. Vol. 30 Day

1,707,031

Employees

Market Cap

4,265,201

Shares Out.

1,022,830

Float

859,078

On/Off Exchange

49%/51%

6 Month Beta

0.23

1 Year Beta

0.56

2 Year Beta

0.67

3 Year Beta

0.54

52 Week Low

2.38

52 Week High

39.48

SMA50

5.12

SMA200

8.34

1 Week

+1.46%

1 Month

+18.13%

3 Month

-35.65%

6 Month

-69.25%

1 Year

-87.59%

2 Year

-94.53%

5 Year

-99.40%

Jan 28, 2022

08:00AM EST HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors. GlobeNewswire Inc

Jan 7, 2022

01:07PM EST Craig-Hallum Upgrades HTG Molecular Diagnostics to Buy, Raises Price Target to $8 Benzinga

Jan 6, 2022

08:13AM EST HTG Molecular Diagnostics Sees Prelim. FY21 sales $8.9M vs $8.84M Est. Benzinga

08:00AM EST HTG Molecular Diagnostics Announces Certain Preliminary GlobeNewswire Inc

Dec 22, 2021

04:07PM EST HTG Completes HTP Product Next-Phase Development Milestone Benzinga

More News

Profile

HTG Molecular Diagnostics Inc. is focused on NGS-based molecular profiling. The Company's proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG's customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

HTGM Stock Summary

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) stock price today is $4.17, and today's volume is 153,572. HTGM is down 0.000% today. The 30 day average volume is 1,707,031. HTGM market cap is 4.265M with 1,022,830 shares outstanding.